• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Early-stage Predictors of the Acute Phase Duration in Uncomplicated COVID-19 Pneumonia

tetano

Editor, Senior Moderator
J Med Virol


. 2020 Jul 9.
doi: 10.1002/jmv.26281. Online ahead of print.
Early-stage Predictors of the Acute Phase Duration in Uncomplicated COVID-19 Pneumonia


Claudio Carallo[SUP] 1 2 [/SUP], Fabiola Pugliese[SUP] 2 3 [/SUP], Cesare Tripolino[SUP] 2 4 [/SUP], Lorenza Lenzi[SUP] 2 3 [/SUP], Chiara Oliveri[SUP] 2 3 [/SUP], Giada Fasani[SUP] 2 5 [/SUP], Giovanni Maria Guarrera[SUP] 2 6 [/SUP], Walter Spagnolli[SUP] 2 5 [/SUP], Susanna Cozzio[SUP] 2 3 [/SUP]



Affiliations

Abstract

Objective: In this study, we aimed to highlight the common early-stage clinical and laboratory variables independently related to the acute phase duration in patients with uncomplicated coronavirus disease (COVID-19) pneumonia.
Methods: In hospitalized patients, the acute phase disease duration was followed using the Brescia-COVID respiratory severity scale (BCRSS). Noninvasive ventilation was administered based on clinical judgment. Patients requiring oropharyngeal intubation were excluded from the study. For parameters to be measured at the hospital entrance, age, clinical history, National Early Warning Score2 (NEWS2, a multiparametric score system), partial pressure of oxygen in arterial blood/fraction of inspired oxygen (P/F ratio), C-reactive protein, and blood cell count were selected.
Results: In 64 patients, age (direct relationship), P/F, and platelet number (inverse relationship) independently accounted for 43% of the acute phase duration of the disease (p<0.001).
Conclusions: For the first time, the present results revealed that the acute phase duration of non-complicated pneumonia, resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is independently predicted from a patient's age, as well as based on the hospital entrance values of P/F ratio and peripheral blood platelet count. This article is protected by copyright. All rights reserved.

Keywords: COVID-19 pneumonia; SARS-CoV-2; disease duration; hospital resources; hospital stay; in-hospital.
 
Back
Top Bottom